Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment

Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p

(2018) et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

(2018) Jean-Charles Soria et al.   NEW ENGLAND JOURNAL OF MEDICINE

BCL11A interacts with SOX2 to control the expression of epigenetic regulators in lung squamous carcinoma

(2018) Kyren A. Lazarus et al.   Nature Communications

Cold atmospheric plasma and iron oxide-based magnetic nanoparticles for synergetic lung cancer therapy

(2018) Wentong Li et al.   FREE RADICAL BIOLOGY AND MEDICINE

Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1

(2017) Shiyu Song et al.   Cell Death & Disease

p21(WAF1) Mediates Cell-Cycle Inhibition, Relevant to Cancer Suppression and Therapy

(2016) Wafik S. El-Deiry   CANCER RESEARCH

The AIM2-like Receptors Are Dispensable for the Interferon Response to Intracellular DNA

(2016) Elizabeth E. Gray et al.   IMMUNITY

New and emerging targeted treatments in advanced non-small-cell lung cancer

(2016) Fred R Hirsch et al.   LANCET

Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer

(2015) Si Ming Man et al.   CELL

Regulation of inflammasome activation

(2015) Si Ming Man et al.   IMMUNOLOGICAL REVIEWS

Whole genome expression profiling in chewing-tobacco-associated oral cancers: a pilot study

(2015) Sanjukta Chakrabarti et al.   MEDICAL ONCOLOGY

Differential expression of inflammasomes in lung cancer cell lines and tissues

(2015) Hui Kong et al.   TUMOR BIOLOGY

Luteolin, ellagic acid and punicic acid are natural products that inhibit prostate cancer metastasis

(2014) Lei Wang et al.   CARCINOGENESIS

Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice

(2014) Sachin P. Patil et al.   NEUROPHARMACOLOGY

Tumour inflammasome-derived IL-1β recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma

(2012) Lih-Chyang Chen et al.   EMBO Molecular Medicine

Inflammasomes in carcinogenesis and anticancer immune responses

(2012) Laurence Zitvogel et al.   NATURE IMMUNOLOGY

Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs

(2011) Xiuwen Tang et al.   FREE RADICAL BIOLOGY AND MEDICINE

Cancer Causes Cardiac Atrophy and Autophagy in a Sexually Dimorphic Manner

(2010) P. F. Cosper et al.   CANCER RESEARCH

Luteolin from Purple Perilla mitigates ROS insult particularly in primary neurons

(2010) Gang Zhao et al.   NEUROBIOLOGY OF AGING

Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells

(2009) Cristina P.R. Xavier et al.   CANCER LETTERS

Restoration of absent in melanoma 2 (AIM2) induces G2/M cell cycle arrest and promotes invasion of colorectal cancer cells

(2009) Georgios Patsos et al.   INTERNATIONAL JOURNAL OF CANCER

AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA

(2009) Teresa Fernandes-Alnemri et al.   NATURE

AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC

(2009) Veit Hornung et al.   NATURE

Inflammation in the development of lung cancer: epidemiological evidence

(2008) Eric A Engels   Expert Review of Anticancer Therapy

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE